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Abstract
Photoactivation and binding of photoactive chemicals to proteins is a known prerequisite for the formation of
immunogenic photoantigens and the induction of photoallergy. The intensive use of products and the availability of new
chemicals, along with an increasing exposure to sun light contribute to the risk of photosensitizing adverse reactions.
Dendritic cells (DC) play a pivotal role in the induction of allergic contact dermatitis. Human peripheral blood monocyte
derived dendritic cells (PBMDC) were thus perceived as an obvious choice for the development of a novel in vitro
photosensitization assay using the modulation of cell surface protein expression in response to photosensitizing agents. In
this new protocol, known chemicals with photosensitizing, allergenic or non-allergenic potential were pre-incubated with
PBMDCs prior to UVA irradiation (1 J/cm
2). Following a 48 h incubation, the expression of the cell surface molecules CD86,
HLA-DR and CD83 was measured by flow cytometry. All tested photosensitizers induced a significant and dose-dependent
increase of CD86 expression after irradiation compared to non-irradiated controls. Moreover, the phototoxicity of the
chemicals could also be determined. In contrast, (i) CD86 expression was not affected by the chosen irradiation conditions,
(ii) increased CD86 expression induced by allergens was independent of irradiation and (iii) no PBMDC activation was
observed with the non-allergenic control. The assay proposed here for the evaluation of the photoallergenic potential of
chemicals includes the assessment of their allergenic, phototoxic and toxic potential in a single and robust test system and
is filling a gap in the in vitro photoallergenicity test battery.
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Introduction
Phototoxicity, photoirritancy and photoallergy are topically
induced health hazards that can be induced by (simulated) sun
light (UV/vis radiation) in the presence of photoreactive agents,
generally referred to as ‘‘photosensitizers’’. The cosmetic and
pharmaceutical industries have a particular interest in the
identification and evaluation of the photosensitizing potential of
new substances before their market launch.
The 7
th Amendment to the Cosmetics Directive (Directive 76/
768/EEC) aims for the complete replacement of animal testing by
2013. However, due to the public concern regarding the use of
animals and the increasing test volume owing to the number of
newly developed chemicals the need for innovative in vitro
alternatives was recognized well before the acceptance of the
amendment. Years ago industrial research groups have developed
and validated the 3T3 Neutral Red Uptake (NRU) phototoxicity
test [1]. These activities resulted in the acceptance by the EU and
the OECD acute phototoxicity test guideline No. 432. This
guideline test can be performed on fibroblasts or keratinocytes in
order to identify the phototoxic potential of a chemical [2].
As an adjunct test the improved protocol of the Photo-red
blood cell (RBC) test can be performed as a more mechanistically
oriented test system [3]. Reconstructed three dimensional
skin models have also been proposed for further evaluation
(unpublished prevalidation data). But to date no accepted alterna-
tive is available to identify the photoallergenic potential of a new
chemical.
Cutaneous photoallergy is understood as a cell mediated
delayed hypersensitivity reaction similar to contact allergy where
the hapten is a photosensitizer that requires light energy for its
activation into a protein reactive compound that may form so
called photoantigens and induce an immune response [4].
Briefly, the absorption of (simulated) sun light (incl. UVA
radiation) leads to an excitation of a single electron from its ground
state to a higher energy level and to the formation of an unstable
intermediate or of reactive photometabolites. The activated
photohapten may then form a complete photoantigen through
covalent binding to a self protein [5]. This photoantigen may then
be captured, processed and the derived photohapten-modified
peptides presented by dendritic or Langerhans cells to naive T
cells in a draining lymph node. This will eventually induce the
production of memory and helper T cells, resulting in an antigen-
specific immune response (sensitization) [6,7]. After a further
challenge with the same or a cross-reacting photohapten, the
immune system will mount an elicitation reaction whose main
clinical symptoms are characterized by eczema, papulovesicles,
blisters and pruritus. In rare cases ’’photosensitization’’ may
generalize beyond the sun exposed area as a persistent light
reaction independent from the photosensitizing material [8,9].
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photoallergens, phototoxic or photoirritant compounds provoke an
acute reaction after the first exposure. Upon light exposure,
photoirritants generate singlet oxygen and other reactive oxygen
species (ROS) that can lead to harmful oxidation of functional cell
components and to tissue damage. Moreover, many photosensitiz-
ers can induce both phototoxic and photoallergenic reactions [10].
Dendritic cells (DC) play a pivotal role in the initiation and
regulation of immune responses. As professional antigen present-
ing cells they are specialized in the uptake and processing of
antigens thereby triggering the complex biological processes
leading to specific T cell activation and maturation. During these
processes DCs undergo diverse phenotypical and functional
changes such as reduced phagocytic ability, upregulated cell
surface expression of co-stimulatory molecules and adhesion
proteins, such as CD86, CD83, CD54, CD40, and MHC II
antigens. In parallel with a modulation of their chemokine
receptor pattern, activated and antigen loaded DCs then migrate
from the peripheral tissue to draining local lymph nodes [11].
The measurement of these phenotypical and functional DC
modifications was central to the development of several in vitro test
protocols for the detection of sensitizers [12,13,14]. Different
approaches based on peripheral blood monocyte derived DCs
(PBMDCs) or DC-like cell lines such as THP-1, U937 and
MUTZ-3 are currently being evaluated and/or validated [15].
We have used DCs derived from peripheral blood primary
monocytes to develop an in vitro assay for the detection of the
photoallergenic potential of chemicals. The modulation of the cell
surface molecules CD86, CD83 and HLA-DR was measured after
DC exposure to known photoallergenic and phototoxic as well as
allergenic and non-allergenic chemicals or to irradiation only.
Reproducible and specific results were obtained. Moreover the
inter-donor variability of basal CD86 expression was minimal.
The test protocol proposed here represents a promising assay for
predicting the photoallergenic potential of chemicals including the
assessment of their allergenic and toxic/phototoxic potential.
Materials and Methods
Chemicals
Chlorpromazine hydrochloride (CPZ, CAS no. 69-09-0), 6-
methylcoumarin (6-MC, CAS no. 92-48-8), musk ambrette (MA,
CAS no. 83-66-9), sparfloxacin (SPFX, CAS no. 110871-86-8),
ketoprofen (KP, CAS no. 22071-15-4) and olaquindox (OLQ,
CAS no. 23696-28-8) were applied as known photoallergenic and
phototoxic agents. Nickel sulphate (NI, CAS no. 10101-97-0) and
a-hexyl cinnamaldehyde (HCA, CAS no. 101-86-0) were used as
known allergens and p-hydroxybenzoic acid (HBA, CAS no. 99-
96-7) was chosen as negative control (all purchased from Sigma,
Germany). Stock solutions of chemicals were prepared in
dimethylsulfoxide or ethanol and further diluted in culture
medium immediately before use. The final concentration of
dimethylsulfoxide or ethanol never exceeded 0.25%.
Cell culture medium
Culture medium was RPMI 1640 containing 10% heat
inactivated (30 min, 56uC) fetal calf serum (FCS Gold, PAA,
Austria), 4 mM L-glutamin, penicillin 100 IU/ml, streptomycin
100 mg/ml (all purchased from PAA, Austria).
Generation of peripheral blood monocyte derived
dendritic cells (PBMDC)
Peripheral blood mononuclear cells were isolated from buffy
coats of healthy donors by ficoll (Lymphocyte Seperation Medium,
PAA, Austria) gradient density centrifugation. Buffy coats were
randomly and anonymously obtained as residual product from
whole blood preservation production. CD1a
2/CD14
+ monocytes
were further enriched by positive depletion using anti-CD14-Ig
coupled magnetic microbeads (Miltenyi, Germany). PBMDCs
were generated by culture of purified monocytes (1610
6/ml) in
culture medium supplemented with 100 IU/ml of interleukin-4
(IL-4) and 200 IU/ml of granulocyte–macrophage colony-stimu-
lating factor (GM-CSF) for five days as previously described [16].
Chemical treatment and irradiation of PBMDCs
PBMDCs (7.5610
5/ml) were seeded in 24-well plates at day 5
and solutions of test chemicals were added. As a first step, the
phototoxicity or cytotoxicity of the chemicals included in the test
set was evaluated within a large concentration range limited only
by their solubility. The concentration inducing phototoxicity or
cytotoxicity around 20% was first determined. The final test range
was then defined by choosing a minimum of 4 lower and one
higher test concentrations. Irradiation experiments were per-
formed using an UV solar simulator (SOL 500, Dr. Ho ¨nle,
Germany) equipped with a H1 filter. The H1 filtered spectral
output (50% transmission at a wavelength of 335 nm) comprises
visible light, UVA and a small amount of UVB (17.3%
transmission at 320 nm) and is described elsewhere [1]. The H1
filtered spectrum is later referred to as UV or UVA. The
irradiances of UVA light were measured with a calibrated UVA-
meter (type No. 37, Dr. Ho ¨nle) prior to each experiment. The
distance of the UV solar simulator to cell culture plate was 30 cm
and irradiation was performed through the cover lid of cell culture
plate (Greiner Bio-one, Germany). During the irradiation
procedure a ventilator was used to maintain a constant ambient
temperature. Chemical treated cells were immediately exposed to
simulated sunlight (UVA radiation of 0.5 J/cm
2 to 4 J/cm
2)o r
kept in the dark and then incubated for 48 h at 37uC/5% CO2.
Flow cytometry analysis
Treated PBMDCs were harvested at day 7 (48 h after exposure
to the test chemicals) and washed with cold phosphate-buffered
saline (PBS). Cells were stained with monoclonal fluorochrome-
coupled antibodies (mAb) or with isotype-matched control
antibodies. The following mAbs were used: Anti-CD86-APC
(clone 2331, FUN-1, lot no. 32914), anti-HLA-DR-APC-Cy7
(clone L243, lot no. 41538) and anti-CD83-FITC (clone HB15e,
lot no. 15128). All mAbs were purchased from Becton Dickinson,
USA. Dead cells were determined and excluded from further
analysis by 7-AAD staining.
PBMDCs were incubated for 15 minutes with mAbs and 10
minutes with 7-AAD. 1610
4 cells were analyzed for each sample
withaFACSCantoII(Becton Dickinson,USA)and the resultswere
processed by FACS DIVA software (Becton Dickinson, USA).
Data analysis and statistics
Changes of surface marker expression after treatment (DCD86)
were calculated relative to untreated controls according to the
following formula:
DCD86+irradiation~%CD86 chemicaltreated=+irradiation
{ % CD86 untreated control=+irradiation
The relative fluorescence intensity (RFI) of HLA-DR was
calculated based on the mean fluorescence intensity (MFI) relative
to untreated controls according to the following formula:
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For each test compound data obtained on PBMDCs obtained
from at least 5 blood donors were analyzed and are presented as
mean values with standard deviation (mean 6 SD). When
indicated in the figure legends, the significance of the difference
between the irradiated DCD86 values and the corresponding non-
irradiated DCD86 values (obtained with test concentrations
inducing ,20% cytotoxicity) was analyzed using Wilcoxon test,
and p-values #0.05 were considered to be significant.
Results
UV-light sensitivity of PBMDCs
In particular ultraviolet radiation (UVA and UVB) can induce
various biological effects including a modulation of the human
immune response through phenotypical and functional changes in
antigen presenting cells or even functional damage of macrophages,
Langerhansor dendritic cells, which canresult in animpaired antigen
presentation capacity and a suppression of the immune response.
In order to develop an in vitro photosensitization assay,
irradiation conditions compatible with the envisaged biological
test system should first be determined. The effects of two
irradiation schemes (measured UVA intensities of 1.7 and
3.4 mW/cm
2) on PBMDCs were first assessed by exposing the
cells to a serial of increasing UVA doses.
The viability of PBMDCs irradiated with 0.5 to 2 J/cm
2 UVA
applied with an intensity of 3.4 mW/cm
2 was not decreased
(Fig. 1A, black diamonds). Slight cytotoxic effects (viability
decreasing from 97% to 90.3%) were observed when the
irradiation dose was increased to 4 J/cm
2. Similar cytotoxic
effects were observed when the same radiation doses were applied
with an intensity of 1.7 mW/cm
2.
The impact of irradiation on the chosen biomarkers (CD86,
CD83 and HLA-DR) expression was examined. No relevant
increase in CD86 expression could be detected at irradiation doses
,1 J/cm
2. Higher doses induced a dose-dependent increase in
CD86 expression (DCD86) up to 20% (Fig. 1A, black columns).
On the other hand, the expression of the maturation marker
CD83 was not affected under these irradiation conditions (Fig. 1B).
With an irradiation intensity of 1.7 mW/cm
2 the HLA-DR
expression first decreased (at 0.5 J/cm
2) to nearly 75% of the non-
irradiated control, and then increased in a dose-dependent manner
up to 140% of control (Fig. 1C, white columns). A similar pattern
(withoutinitialdecreaseat0.5 J/cm
2)wasobservedwhenaradiation
intensity of 3.4 mW/cm
2 was used (Fig. 1C, black columns).
The radiation conditions (dose and intensity) to be used in the
photosensitization assay should neither induce cytotoxicity nor
relevant alterations in cell surface protein expression but still
provide enough energy to activate photosensitizers. Our data
indicate that a radiation dose of 1 J/cm
2 applying an intensity of
3.4 mW/cm
2 fulfils the first two conditions. These radiation
conditions (1 J/cm
2 UVA with 3.4 mW/cm
2) were considered as
appropriate and used for all further experiments.
Analysis of inter-donor variability of the basal expression
level of the chosen biomarkers in non-irradiated and
irradiated PBMDCs
Donor to donor variability in the basal expression of maturation
markers by PBMDCs has been reported in previous studies
[14,17] as a critical point. To evaluate the magnitude of that
variability, we investigated the basal CD86, CD83 and HLA-DR
surface expression in non-irradiated and irradiated PBMDCs
Figure 1. Effects of UVA radiation on the expression of CD86,
CD83, HLA-DR and viability of PBMDCs. Cells were exposed to the
indicated UVA doses (X axis) with intensities of 1.7 mW/cm
2 (open
columns) and 3.4 mW/cm
2 (black columns). The expression of CD86 (A),
CD83 (B), HLA-DR (C) was analyzed by flow cytometry 48 h later. The
correspondingcellviability(rightY axis) is indicated forradiation intensities
of 1.7 mW/cm
2 (open diamonds, dashed line) and 3.4 mW/cm
2 (black
diamonds, solid line). Mean values 6 standard deviation of at least 5
independent donors are indicated. RFI: Relative fluorescence intensity.
doi:10.1371/journal.pone.0015221.g001
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expression level of both control and irradiated cells was relatively
low (median values below 30%) with a very limited variance
(Fig. 2A). These results were confirmed during a second study
performed in our laboratory. The analysis of an extensive data
pool over multiple projects, extensive time periods and different
laboratory personnel revealed a very stable basal expression of
CD86 among donors (n=397) [18]. Moreover, the overall CD83
expression was low (2.75% without irradiation and 3.3% with
irradiation) indicating the immature status of the cells and a very
limited variability (Fig. 2B). The HLA-DR expression of the same
pool of donors was not influenced by UVA irradiation (as
compared to controls, see Fig. 2C) but the extent of donor to
donor variability was greater than that observed for CD86 and
CD83.
Induction of CD86 expression in response to
photoallergens after irradiation
To evaluate whether this in vitro photosensitization assay can
detect photosensitizing chemicals using the chosen irradiation
conditions (1 J/cm
2 UVA at 3.4 mW/cm
2), the following
potential photosensitizers were selected and tested: chlorproma-
zine (CPZ, psychoactive agent), 6-methylcoumarin (6-MC,
fragrance), musk ambrette (MA, fragrance), sparfloxacin (SPFX,
antibiotic), ketoprofen (KP, nonsteroidal anti-inflammatory drug),
olaquindox (OLQ, antibiotic and feed additive). The non-
photoallergenic allergens a-hexylcinnamaldehyde (HCA) and
nickel sulphate (NI) as well as the non-allergenic 4-hydroxybenzoic
acid (HBA) were used as control substances.
PBMDCs were first exposed to increasing concentrations of
CPZ (known photosensitizer with photoallergenic and phototoxic
properties) with and without irradiation. CD86, CD83 and HLA-
DR surface expression of photosensitizer treated, non-irradiated as
well as photosensitizer treated, irradiated cells and controls were
compared (Fig. 3). Minor or irrelevant modifications in CD83
expression were observed (CPZ treated, irradiated cells versus
irradiated control, Fig. 3A) and only a slight increase in HLA-DR
expression was induced by CPZ under irradiation (Fig. 3B). In
contrast, a marked increase in CD86 expression was observed
under those same conditions (Fig. 3C). CD86 modulation
calculated as the difference between the results obtained for the
treated sample and the corresponding untreated control (DCD86)
revealed a dose-effect relationship in response to CPZ after
irradiation (Fig. 3D, black columns). Increasing concentrations
from 2.5 mMt o5mM induced a 2.2-fold increase of DCD86 (11%
to 24%). This represents a very significant increase in CD86
expression compared to the low DCD86 values obtained without
irradiation at 5 mM. Negative DCD86 values were due to
biological variability. Moreover CPZ treatment induced dose-
related cytotoxic effects with irradiation but had no cytotoxic effect
without irradiation.
Since CD86 was markedly upregulated in response to irradiated
CPZ (in contrast to CD83 and HLA-DR), it was chosen as the sole
marker for the analysis of the following experiments.
6-MC (responsible for photocontact dermatitis reactions)
induced a dose-dependent increase in CD86 expression after
irradiation (.40% DCD86, Fig. 4A). The difference with the
DCD86 obtained without irradiation was significant at concen-
trations .600 mM.
6-MC without irradiation induced a DCD86 increase .20%
compared to the untreated control. No cytotoxic effects were
detected within the tested concentration range without irradiation.
Under irradiation, a slight cytotoxicity (16%) was detected at the
highest test concentration.
MA, a known allergenic and photoallergenic fragrance [19] was
tested with PBMDCs isolated from 6 different donors. A dose-
related increase in CD86 expression (DCD86) was observed with
or without irradiation, the increase being nevertheless significantly
higher after irradiation (Fig. 4B). DCD86 values exceeded 50% at
30 mM whereas cell viability decreased below 80% at 50 mM
under irradiation. On the other hand, non-irradiated MA had no
cytotoxic effect over the whole tested concentration range.
SPFX, an extreme phototoxic chemical with weak photoaller-
genic properties [20] induced a significant DCD86 increase
(Fig. 4C) under irradiation conditions compared to non-irradiated
cells. At low concentrations (#10 mM) it already induced a
DCD86 level .20% without cytotoxic effect. At higher doses with
Figure 2. CD86, CD83 and HLA-DR expression of PBMCDs
irradiated with 1 J/cm
2 UVA. The expression of CD86 (A), CD83 (B),
HLA-DR (C) was analyzed by flow cytometry on non-irradiated (- UVA) or
irradiated (1 J/cm
2 UVA with 3.4 mW/cm
2) PBMDCs. Box plots indicate
median (horizontal line), 1
st,3
rd quartile (box) and maxima/minima-
values (T-bars) of at least 40 independent donors. MFI: Mean
fluorescence intensity.
doi:10.1371/journal.pone.0015221.g002
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50 mM). In contrast, without irradiation, no relevant cytotoxicity
was detected.
Exposure to KP, a photoallergenic nonsteroidal anti-inflamma-
tory drug, induced after irradiation a dose-dependent increase of
DCD86 .25% without cytotoxic effects up to 300 mM (Fig. 4D,
black columns and black diamonds). At high doses (.350 mM),
irradiated KP induced phototoxic effects. On the other hand, KP
alone (without irradiation) had no relevant effect on the CD86
expression or on the cell viability.
OLQ, a photoallergenic feed additive and antibiotic, induced
under radiation conditions a dose-related increase in CD86
expression (DCD86) values .30% at concentrations .400 mM
(Fig. 4E, black columns) and cytotoxicity was detected at the
Figure 3. Expression of CD83, HLA-DR, CD86 and viability of PBMDCs exposed to CPZ and UVA radiation. Histogram overlays show
CD83 (A), HLA-DR (B) and CD86 expression (C) measured by flow cytometry on irradiated (1 J/cm
2 with 3.4 mW/cm
2) PBMDCs. In each histogram the
dotted line and thin dashed line indicate the results obtained with the isotype control or untreated control respectively. The results obtained with
PBMDCs exposed to CPZ are indicated by a solid line (2.5 mM) or a heavy solid line (5 mM). D: DCD86 measured on PBMDCs exposed to the indicated
CPZ concentrations (X axis) with (black columns) or without (open columns) UVA radiation (1 J/cm
2 with 3.4 mW/cm
2). The viability (right Y axis) of
non-irradiated (open squares, dashed line) and irradiated cells (black diamonds, solid line) is also indicated. Mean values for cell viability and mean 6
standard deviation for DCD86 expression of at least 5 independent donors are shown. Negative DCD86 values were due to biological variability.
Asterisk indicates significant difference between irradiated and non-irradiated DCD86 values (p,0.05, Wilcoxon test).
doi:10.1371/journal.pone.0015221.g003
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were incubated with the indicated (X axis) concentrations of photoallergens and allergens with or without exposure to 1 J/cm
2 UVA. The DCD86
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irradiated OLQ treatment resulted in limited CD86 modulation
(DCD86,10%) and did not influence cell viability.
To determine whether the described photosensitization assay is
able to distinguish photosensitizers from allergens and non-
allergens, non-photosensitizing allergens (for example HCA and
NI) were used as controls. As expected, the fragrance compound
HCA induced relevant and analogous increases of CD86
expression with or without irradiation (DCD866UV .30% at
200 mM, see Fig. 4F). The cytotoxic effects were similarly induced
at concentrations .200 mM under both conditions.
Likewise, NI induced very similar dose-dependent increases of
the CD86 expression with or without irradiation (DCD86.55% at
200 mM, see Fig. 5A). The radiation condition had no impact on
the relatively weak NI induced cytotoxicity observed at 300 mM.
HBA, a non-allergenic and non-photoallergenic compound was
chosen as negative control. Cell viability and the modulation of
CD86 expression (DCD86) in response to 500 mM–4 mM HBA
with or without irradiation are shown in Fig. 5B. As expected, no
relevant modulation of the CD86 expression (DCD86,10%) was
measured with or without irradiation and no cytotoxic effect was
observed up to the highest test concentration (4 mM).
Discussion
The objective of this study was to develop and evaluate an in
vitro model for the detection and characterization of the
photoallergenic potential of chemicals. The in vitro approach
presented here uses the modulation of certain proteins expressed
on the surface of PBMDCs exposed to photoallergens with and
without irradiation as a readout system.
First, radiation conditions compatible with the envisaged
photosensitization assay had to be defined. The applied UVA
dose should have no relevant impact on the chosen surface
markers (CD86, HLA-DR and CD83) as well as on the viability of
the PBMDCs. Initially, the radiation conditions proposed for the
3T3 NRU phototoxicity test [2] were adapted to our system.
Dose-dependent increases in CD86 and HLA-DR (but not CD83)
expression were observed at radiation doses .1 J/cm
2 UVA. A
10–15% cytotoxicity was induced at 4 J/cm
2 (UV induced
apoptosis, see Timares et al. [21]). This is similar to the results
published by Mittelbrunn et al. [22] who reported a partial
maturation of PDMDCs and approx. 33% cytotoxicity after
irradiation with 5 J/cm
2 UVA and 0.4 J/cm
2 UVB generated by
a xenon solar simulator.
In contrast, a radiation dose of 1 J/cm
2 had no effect on the
three chosen activation markers or on the PBMDCs viability.
These radiation conditions (1 J/cm
2 UVA, 3.4 mW/cm
2) were
considered as appropriate and used for all further experiments.
Donor to donor variability in the basal expression of maturation
markers by PBMDCs has been reported as a critical point in
previous studies [14,17,23,24] and was often considered as an
obstacle to the use of PBMDCs for the development of in vitro
sensitization tests and DC-like cell lines were perceived as better
Figure 5. CD86 expression and viability of PBMDCs exposed to nickel sulphate and p-hydroxybenzoic acid. PBMDCs were incubated
with the indicated (X axis) concentrations of nickel sulphate (A) and p-hydroxybenzoic acid (B) with or without exposure to 1 J/cm
2 UVA. The DCD86
values (columns) and the cell viability (lines) were measured by flow cytometry without (open columns/squares) or with UVA irradiation (black
columns/diamonds) after exposure to the test compounds. Mean values for cell viability and mean 6 standard deviation for the DCD86 values
measured on the PBMCDs from at least 5 independent donors are shown. Negative DCD86 values were due to biological variability. Asterisk indicates
significant difference between irradiated and non-irradiated DCD86 values (p,0.05, Wilcoxon test).
doi:10.1371/journal.pone.0015221.g005
values (columns) and the cell viability (lines) were measured by flow cytometry without (open columns/squares) or with UVA irradiation (black
columns/diamonds) after exposure to the following compounds: A: 6-methylcoumarin. B: musk ambrette. C: sparfloxacin. D: ketoprofen. E:
olaquindox. F: a-hexylcinnamaldehyde. Mean values for cell viability and mean 6 standard deviation for the DCD86 expression values measured on
the PBMCDs from at least 5 independent donors are shown. Negative DCD86 values were due to biological variability. Asterisk indicates significant
difference between irradiated and non-irradiated DCD86 values (p,0.05, Wilcoxon test).
doi:10.1371/journal.pone.0015221.g004
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gated by measuring the expression of CD86, CD83 and HLA-DR
on non-irradiated and irradiated, immature PBMDCs. Their
expression levels were shown to be very similar in cells isolated
from a large set of different donors. This limited donor variability
was already published by Coutant et al. [25] and has been
extensively studied and recently confirmed by our group (n=397;
median CD86 expression 26.7%, 1
st quartile 17.7%, 3
rd quartile
40.5%) [18]. However, an intrinsic variability of primary cells is to
be expected due to the diversity in individual immune responses to
allergens in the population. In order to take advantage of this
existing but limited variability, we decided to test the photoaller-
genic potential of a chemical with PBMDCs obtained from a
minimum of 5 independent donors.
CPZ, a known photosensitizer with photoallergenic and
phototoxic properties, was tested with and without irradiation
and the induced modulation of CD86, CD83 and HLA-DR
expressions as well as cell viability were measured by flow
cytometry and compared 48 h after treatment. Only minor
modifications of HLA-DR and CD83 expressions could be
detected. In contrast, CD86 measurements revealed a significant
dose-effect relationship in response to CPZ after irradiation.
Moreover, CPZ treatment induced dose-related cytotoxic effects
with irradiation but had no cytotoxic effect without irradiation.
CD86 induction was thus perceived as a suitable endpoint for
photoallergen detection. This is consistent with the numerous
reports indicating CD86 as one of the most promising amongst
frequently tested DC activation markers in skin sensitization
testing [15].
Further chemicals with documented photoallergenic and
phototoxic potentials were used to evaluate the performance of
the proposed in vitro photosensitization assay. The DCD86 values
induced by the photoallergens after irradiation were always more
than 15% higher than the corresponding values obtained without
irradiation. This difference (15%) between the DCD86 values
measured with and without irradiation could be used as a putative
cut off value for detecting photoallergens. As an alternative, a
statistically significant difference between the DCD86 values
obtained with or without irradiation might be considered. Further
tests with an extensive set of chemicals will be necessary to get a
robust cut off value.
When testing CPZ it was observed that the induction of CD86
expression appeared at doses close to or overlapping with those
inducing cytotoxic effects as a result of both photoallergenic and
phototoxic reactivity. In another study, we could demonstrate that
the presence of 33% dead cells induced the unspecific upregula-
tion of the CD86 expression [18]. These unspecific cytotoxic
effects due to damaged and/or dead cells have to be excluded and
we propose that data obtained with test concentrations inducing
.20% cytotoxicity should not be considered for the determination
of photoallergenicity.
Using our assay, MA a known allergenic and photoallergenic
fragrance [19,26] induced a dose-related increase in CD86
expression with or without irradiation, the increase being
significantly higher after irradiation. We could thus classify MA
as an allergen and a photoallergen with phototoxic properties.
This is consistent with available in vivo data indicating that contact
dermatitis to MA can be exacerbated by irradiation [19,27].
Moreover, the validated 3T3 NRU phototoxicity test also
classified MA as phototoxic [28].
The fragrance 6-MC was detected as a potent photoallergen
consistent with other in vivo and in vitro data indicating a role of
photodimerized 6-MC esters in 6-MC photoallergenicity [29,30].
Using our protocol, the highest test concentration induced a slight
phototoxic effect suggesting a pronounced cytotoxicity at concen-
trations .1 mM. Though cytotoxicity of irradiated 6-MC was also
detected in the THP-1 cell line based in vitro approach described
by Hoya et al. [31] and its phototoxicity partially attributed to the
formation of singlet oxygen [32], it was concluded that 6-MC is a
photoallergen only. Here, non-irradiated 6-MC also resulted in a
relevant CD86 induction indicating an allergenic potential
consistent with Buehler et al. [33] who considered 6-MC as
contact allergen with weak phototoxic potential.
An inverse correlation between phototoxic effects and photo-
allergenicity was demonstrated for some flouroquinolone antibi-
otics. For example, SPFX is known as an extreme phototoxic
chemical with weak photoallergenic properties [20]. Its weak
photoallergenicity is likely outweighed by its strong phototoxicity,
e.g. when high concentrations are applied in medical formulations.
In our test, irradiated SPFX induced a relevant CD86 modulation
already at low concentrations (#10 mM) without cytotoxic effect,
thus indicating a photoallergenic potential. Interestingly, photo-
haptenic properties were also described by Hino et al. [34] where
SPFX treatment of THP-1 cells only resulted in enhanced HLA-
DR but not CD86 or CD54 expression.
In recent years, increasing incidences of photoallergic reactions
to non-steroidal anti-inflammatory drugs, mainly KP, were
reported. Our in vitro test clearly classified KP as a photoallergen
and phototoxin consistent with previous in vivo and in vitro studies
[35]. KP is also known to elicit contact dermatitis [36]. Since
allergenic and photoallergenic concentrations are not necessarily
identical, we hypothesized that higher KP concentrations would
be required in our assay to reveal KP’s allergenic potential
(without irradiation) than its photoallergenic potential. Indeed, KP
induced a dose-dependent increase of CD86 expression after
irradiation whereas without irradiation it had no relevant effect on
the CD86 expression or on the cell viability.
Using our test protocol, the photoallergenic feed additive OLQ
induced significant and dose-related increases in CD86 expres-
sion and cytotoxicity was detected at the highest test concentra-
tion. In contrast, non-irradiated OLQ treatment resulted in
limited CD86 modulation and did not influence cell viability.
Since the DCD86 values obtained with or without irradiation
showed a difference of more than 30% our results are consistent
with the photoallergenic and phototoxic properties deduced from
other studies [9,37].
HCA demonstrated a very similar and dose-dependent CD86
induction with and without irradiation and we thus concluded that
HCA has no photoallergenic but an allergenic potential. HCA was
classified as a contact sensitizer serving as a positive control in the
LLNA and tested in other in vitro sensitizations tests [15,38]. The
cytotoxicity was also similar under both conditions indicating only
toxic (but no phototoxic) properties at high concentrations. This
result is also consistent with data obtained from a photohaemolysis
test [39].
NI induced similar dose-dependent increases of the CD86
expression under both conditions and irradiation had no influence
on its relatively weak cytotoxicity. This is the reaction pattern
expected for non-photosensitizing allergens such as NI (and HCA)
and our in vitro results were in complete agreement with its clinical
relevance (induction of allergic contact dermatitis) or its use as a
model for metal allergens [40,41,42].
HBA was tested as a typical non-allergenic and non-photo-
allergenic compound. As expected, no relevant modulation of the
CD86 expression was detected with or without irradiation and no
cytotoxic effect was observed up to the highest test concentration.
These results are again in full agreement with already published in
vitro tests and LLNA study results [43,44].
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be clearly distinguished from allergens. Chemicals with a
photoallergenic potential also showed phototoxic effects at higher
concentration ranges that could be clearly determined in our in
vitro assay. However, it may not be excluded that highly phototoxic
drugs are able to induce additional photoallergic reactions since
many drugs are able to bind to biomolecules after activation. This
consideration is constantly supported by reports describing
photoallergic reactions induced by drugs considered as photo-
irritants. However, the chemical process leading to protein
photobinding should be intensively investigated since our present
understanding is insufficient for a clear distinction of photoaller-
gens and photoirritants in vitro [45]. In addition photopatch tests
do not lead to an unambiguous clinical determination of
photoallergic and phototoxic reactions since multiple factors may
influence dermal responses to chemicals, e.g. pre-existing skin
disorders or cross reactions [46].
Due to the 7
th Amendment of the European Cosmetic
Directive, the cosmetic industry needs to finalize the development
of alternatives to animal tests by 2013. In vitro assays have already
been developed for acute phototoxicity testing and the OECD
proposes to use the validated 3T3 NRU phototoxicity test which
can be performed on fibroblasts or keratinocytes [47]. However,
these cell types play different roles in the induction of photoallergy
and a DC based assay would represent a critical and major
addition to the available test panel.
In summary, this novel in vitro photosensitization assay based on
primary PBMDCs yields reproducible and specific results allowing
a precise determination of the photosensitizing characteristics of
the tested compounds. The described assay represents a promising
and robust test system for predicting the photoallergenic potential
of chemicals including the assessment of their allergenic and
toxic/phototoxic potential and is filling a gap in the in vitro
photoallergenicity test battery.
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